Gabapentin Modulates HCN4 Channel Voltage-Dependence
- PMID: 28871229
- PMCID: PMC5566583
- DOI: 10.3389/fphar.2017.00554
Gabapentin Modulates HCN4 Channel Voltage-Dependence
Abstract
Gabapentin (GBP) is widely used to treat epilepsy and neuropathic pain. There is evidence that GBP can act on hyperpolarization-activated cation (HCN) channel-mediated Ih in brain slice experiments. However, evidence showing that GBP directly modulates HCN channels is lacking. The effect of GBP was tested using two-electrode voltage clamp recordings from human HCN1, HCN2, and HCN4 channels expressed in Xenopus oocytes. Whole-cell recordings were also made from mouse spinal cord slices targeting either parvalbumin positive (PV+) or calretinin positive (CR+) inhibitory neurons. The effect of GBP on Ih was measured in each inhibitory neuron population. HCN4 expression was assessed in the spinal cord using immunohistochemistry. When applied to HCN4 channels, GBP (100 μM) caused a hyperpolarizing shift in the voltage of half activation (V1/2) thereby reducing the currents. Gabapentin had no impact on the V1/2 of HCN1 or HCN2 channels. There was a robust increase in the time to half activation for HCN4 channels with only a small increase noted for HCN1 channels. Gabapentin also caused a hyperpolarizing shift in the V1/2 of Ih measured from HCN4-expressing PV+ inhibitory neurons in the spinal dorsal horn. Gabapentin had minimal effect on Ih recorded from CR+ neurons. Consistent with this, immunohistochemical analysis revealed that the majority of CR+ inhibitory neurons do not express somatic HCN4 channels. In conclusion, GBP reduces HCN4 channel-mediated currents through a hyperpolarized shift in the V1/2. The HCN channel subtype selectivity of GBP provides a unique tool for investigating HCN4 channel function in the central nervous system. The HCN4 channel is a candidate molecular target for the acute analgesic and anticonvulsant actions of GBP.
Keywords: HCN4; epilepsy; gabapentin; pain; spinal cord.
Figures






Similar articles
-
Involvement of hyperpolarization-activated, cyclic nucleotide-gated cation channels in dorsal root ganglion in neuropathic pain.Sheng Li Xue Bao. 2008 Oct 25;60(5):579-80. Sheng Li Xue Bao. 2008. PMID: 18958363
-
Molecular and functional analysis of hyperpolarisation-activated nucleotide-gated (HCN) channels in the enteric nervous system.Neuroscience. 2004;129(3):603-14. doi: 10.1016/j.neuroscience.2004.08.027. Neuroscience. 2004. PMID: 15541882
-
Local anesthetic inhibits hyperpolarization-activated cationic currents.Mol Pharmacol. 2011 May;79(5):866-73. doi: 10.1124/mol.110.070227. Epub 2011 Feb 8. Mol Pharmacol. 2011. PMID: 21303986 Free PMC article.
-
Hyperpolarization-activated and cyclic nucleotide-gated channel proteins as emerging new targets in neuropathic pain.Rev Neurosci. 2019 Jul 26;30(6):639-649. doi: 10.1515/revneuro-2018-0094. Rev Neurosci. 2019. PMID: 30768426 Review.
-
Cardiac and neuronal HCN channelopathies.Pflugers Arch. 2020 Jul;472(7):931-951. doi: 10.1007/s00424-020-02384-3. Epub 2020 May 18. Pflugers Arch. 2020. PMID: 32424620 Review.
Cited by
-
HCN Channels: New Therapeutic Targets for Pain Treatment.Molecules. 2018 Aug 21;23(9):2094. doi: 10.3390/molecules23092094. Molecules. 2018. PMID: 30134541 Free PMC article. Review.
-
A Novel Flow Cytometry-Based Assay for the Identification of HCN4 CNBD Ligands.Pharmaceuticals (Basel). 2023 May 7;16(5):710. doi: 10.3390/ph16050710. Pharmaceuticals (Basel). 2023. PMID: 37242492 Free PMC article.
-
In silico Screening and Behavioral Validation of a Novel Peptide, LCGA-17, With Anxiolytic-Like Properties.Front Neurosci. 2021 Aug 2;15:705590. doi: 10.3389/fnins.2021.705590. eCollection 2021. Front Neurosci. 2021. PMID: 34421525 Free PMC article.
-
Bibliometric analysis of hyperpolarization-activated cyclic nucleotide-gated (HCN)channels research (2004-2020).Channels (Austin). 2022 Dec;16(1):49-59. doi: 10.1080/19336950.2021.2020005. Channels (Austin). 2022. PMID: 35235763 Free PMC article. No abstract available.
-
The hyperpolarization-activated cyclic nucleotide-gated 4 channel as a potential anti-seizure drug target.Br J Pharmacol. 2020 Aug;177(16):3712-3729. doi: 10.1111/bph.15088. Epub 2020 Jun 17. Br J Pharmacol. 2020. PMID: 32364262 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials